BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Akeso Begins Phase III Trial of Ivonescimab for Hard-to-Treat Advanced Colorectal Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully enrolled in the registration Phas...

July 16, 2025 | News

Taiwan’s Senhwa Biosciences’ CX-5461 Selected by U.S. National Cancer Institute for Major Oncology Research Programme

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious d...

July 16, 2025 | News

Concord Healthcare Delivers China’s First Proton Therapy for Choroidal Malignant Melanoma

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), whic...

July 15, 2025 | News

Thermo Fisher Scientific Expands Rapid CGP Access with Oncomine™ Comprehensive Assay Plus on Genexus™ System

Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* hel...

July 15, 2025 | News

Amarna Therapeutics and NorthX Biologics Advance Nimvec™ AM510 Toward Clinical Trials for Type 1 Diabetes

Fast-Tracking Clinical Readiness: The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 ...

July 14, 2025 | News

Sartorius Stedim Biotech and Sensible Biotechnologies Forge Alliance to Scale Cell-Based mRNA Manufacturing

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, and Sensible Biotechnologies, a pioneer in cell-based design a...

July 11, 2025 | News

Earendil Labs Completes First Cohort Dosing in Phase 1 Trial of Novel Anti-TL1A Antibody HXN-1001

Earendil Labs, an AI-empowered biotechnology company, announced that it has completed cohort 1 dosing in a phase 1 trial for a novel anti-TL1A antibo...

July 11, 2025 | News

Medidata Expands Partnership with NHMRC Clinical Trials Centre to Accelerate Innovation in Australian Clinical Research

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and rai...

July 10, 2025 | News

Bio-Rad Launches Four New ddPCR Platforms Following Stilla Technologies Acquisition

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of four ...

July 09, 2025 | News

SCG Cell Therapy Secures China NMPA IND Approval for First Cell Therapy Targeting Chronic Hepatitis B

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announ...

July 08, 2025 | News

ImmunityBio Secures First International Approval for ANKTIVA® in the UK for Bladder Cancer Treatment

ANKTIVA, a first-in-class, lymphocyte-stimulating agent, works synergistically with BCG to activate and proliferate natural killer (NK) and T cells, he...

July 08, 2025 | News

InnoCare Pharma Receives IND Approval in China for Novel B7-H3 Targeted ADC ICP-B794

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the Inves...

July 07, 2025 | News

Akeso Doses First Patient in Phase Ia Trial of AK146D1, the World’s First Bispecific ADC Targeting Trop2 and Nectin4

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a...

July 04, 2025 | News

Thermo Fisher Secures FDA Approval for Oncomine Dx Express Test as Companion Diagnostic for Dizal’s ZEGFROVY

Thermo Fisher Scientific, the world leader in serving science, announced the U.S. Food and Drug Administration (FDA) has approved the Oncomine&t...

July 04, 2025 | News

Stay Connected